This document defines failure to thrive and outlines its causes and evaluation process. Failure to thrive is defined as weight or growth below major percentiles. Causes include inadequate intake due to issues with appetite, ingestion, or food availability; altered growth regulation from prenatal or genetic factors; calorie wasting from vomiting or malabsorption; and increased caloric needs. Evaluation involves assessing growth data, medical history, nutrition, development, a feeding observation, and labs if indicated. Hospitalization may be needed if abuse is suspected or for severe cases.
Prevalence of obesity.Body composition & body shape (body fat distribution ) and CVD risk .Mechanisms linking obesity with cardiovascular disease.Fat-but-Fit Paradigm and CVD,The Relationship of Metabolic Risk Factors and Cardiorespiratory Fitness. Metabolically Healthy but Obese ( MHO ) Phenotype and CVD.Obesity Paradox in Patients With CVD
Dietary guidelines are accused to be the key reason for obesity and diabetes epidemic. This slide deck shows why they are not. Junk food diet is the key reason.
Prevalence of obesity.Body composition & body shape (body fat distribution ) and CVD risk .Mechanisms linking obesity with cardiovascular disease.Fat-but-Fit Paradigm and CVD,The Relationship of Metabolic Risk Factors and Cardiorespiratory Fitness. Metabolically Healthy but Obese ( MHO ) Phenotype and CVD.Obesity Paradox in Patients With CVD
Dietary guidelines are accused to be the key reason for obesity and diabetes epidemic. This slide deck shows why they are not. Junk food diet is the key reason.
Για τις νέες προκλήσεις που αντιμετωπίζουμε έκανε λόγο ο Θόδωρος Σκυλακάκης
Στο μείζον θέμα της πρόληψης στον τομέα της υγείας αλλά και τις νέες προκλήσεις που προκύπτουν έκανε λόγο ο ευρωβουλευτής του ΕΛΚ και ιδρυτικό στέλεχος της Δημοκρατικής Συμμαχίας κ. Θόδωρος Σκυλακάκης σε εκδήλωση με θέμα
«Πρόληψη: στρατηγική επιλογή για την πολιτική δημόσιας υγείας στην Ελλάδα και την Ε.Ε.».
Σύμφωνα με τον έλληνα ευρωβουλευτή «όλοι είναι υπέρ της πρόληψης, στο τέλος όμως κανείς δεν ενδιαφέρεται να πάρει πρωτοβουλίες». Ωστόσο ο κ. Σκυλακάκης τόνισε ότι «δεν είναι ελληνικό αλλά ευρωπαϊκό φαινόμενο».
Παράλληλα έκανε λόγο για τις νέες προκλήσεις που έχουμε να αντιμετωπίσουμε όπως η γήρανση του πληθυσμού, η υπόθεση του ανθρώπινου γονιδιώματος αλλά και οι δυνατότητες που έχει το marketing στον τομέα της πρόληψης.
Όσον αφορά το ανθρώπινο γονιδίωμα (αποτελείται από το σύνολο των γονιδίων ενός οργανισμού και κατευθύνει την φυσική ανάπτυξη και την συμπεριφορά του), ο κ. Σκυλακάκης ανέφερε ότι σε 3-4 χρόνια θα υπάρχει η δυνατότητα εξέτασης γονιδιωμάτων με 100 δολάρια.
Στην εκδήλωση ήταν καλεσμένος και ο βουλευτής του ΠΑΣΟΚ και καθηγητής στο London School of Economics κ. Η. Μόσιαλος, ο οποίος όμως δεν κατάφερε να παρευρεθεί λόγω της κακοκαιρίας.
Invited lecture by Dr Sujoy Dasgupta in the Webinar on “PCOS Advocacy” by Endocrinology Committee of FOGSI (Federation of Obstetric and Gynaecological Societies of India), held in September, 2020
Gordon Flynn is an Intensivist and an Anaesthetist from Prince of Wales hospital in Sydney. Here he gives an entertaining and thought provoking talk on the big topic of obesity in ICU. Leave comments below on ICN!
Για τις νέες προκλήσεις που αντιμετωπίζουμε έκανε λόγο ο Θόδωρος Σκυλακάκης
Στο μείζον θέμα της πρόληψης στον τομέα της υγείας αλλά και τις νέες προκλήσεις που προκύπτουν έκανε λόγο ο ευρωβουλευτής του ΕΛΚ και ιδρυτικό στέλεχος της Δημοκρατικής Συμμαχίας κ. Θόδωρος Σκυλακάκης σε εκδήλωση με θέμα
«Πρόληψη: στρατηγική επιλογή για την πολιτική δημόσιας υγείας στην Ελλάδα και την Ε.Ε.».
Σύμφωνα με τον έλληνα ευρωβουλευτή «όλοι είναι υπέρ της πρόληψης, στο τέλος όμως κανείς δεν ενδιαφέρεται να πάρει πρωτοβουλίες». Ωστόσο ο κ. Σκυλακάκης τόνισε ότι «δεν είναι ελληνικό αλλά ευρωπαϊκό φαινόμενο».
Παράλληλα έκανε λόγο για τις νέες προκλήσεις που έχουμε να αντιμετωπίσουμε όπως η γήρανση του πληθυσμού, η υπόθεση του ανθρώπινου γονιδιώματος αλλά και οι δυνατότητες που έχει το marketing στον τομέα της πρόληψης.
Όσον αφορά το ανθρώπινο γονιδίωμα (αποτελείται από το σύνολο των γονιδίων ενός οργανισμού και κατευθύνει την φυσική ανάπτυξη και την συμπεριφορά του), ο κ. Σκυλακάκης ανέφερε ότι σε 3-4 χρόνια θα υπάρχει η δυνατότητα εξέτασης γονιδιωμάτων με 100 δολάρια.
Στην εκδήλωση ήταν καλεσμένος και ο βουλευτής του ΠΑΣΟΚ και καθηγητής στο London School of Economics κ. Η. Μόσιαλος, ο οποίος όμως δεν κατάφερε να παρευρεθεί λόγω της κακοκαιρίας.
Invited lecture by Dr Sujoy Dasgupta in the Webinar on “PCOS Advocacy” by Endocrinology Committee of FOGSI (Federation of Obstetric and Gynaecological Societies of India), held in September, 2020
Gordon Flynn is an Intensivist and an Anaesthetist from Prince of Wales hospital in Sydney. Here he gives an entertaining and thought provoking talk on the big topic of obesity in ICU. Leave comments below on ICN!
Dr Pravin John and Dr John Thanakumar, Anurag Hospital, Coimbatore present the differences between metabolic and obesity surgery - dept of advanced laparoscopy and obesity
Obesity is a condition in which excess body fat has accumulated to an extent that health may be negatively affected. Obesity means having too much body fat. Person\'s weight is greater than what\'s considered healthy for his or her height. Obesity is a serious and rising health epidemic in our country.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
8. Other definitionOther definition
Change of growth that has crossed twoChange of growth that has crossed two
major growth percentiles (i.e. from abovemajor growth percentiles (i.e. from above
the 75th percentile to below the 25th).the 75th percentile to below the 25th).
9. Attained growthAttained growth
Weight <3rd percentile on NCHS growthWeight <3rd percentile on NCHS growth
chartchart
Weight for height <5th percentile on NCHSWeight for height <5th percentile on NCHS
growth chartgrowth chart
Weight 20% or more below ideal weight forWeight 20% or more below ideal weight for
heightheight
Triceps skinfold thickness < 5 mmTriceps skinfold thickness < 5 mm
10. Rate of growthRate of growth
Depressed rate of weight gainDepressed rate of weight gain
<20 g/d from 0 to 3 months of age<20 g/d from 0 to 3 months of age
<15 g/d from 3 to 6 months of age<15 g/d from 3 to 6 months of age
Falloff from previously established growth curveFalloff from previously established growth curve
Downward crossing of >2 major percentiles onDownward crossing of >2 major percentiles on
NCHS growth chartNCHS growth chart
Documented weight lossDocumented weight loss
18. c)Unavailability of foodc)Unavailability of food
Inappropriate feeding techniqueInappropriate feeding technique
Insufficient/inadequate volume of foodInsufficient/inadequate volume of food
Inappropriate food for ageInappropriate food for age
Withholding of food (abuse, neglect)Withholding of food (abuse, neglect)
34. COMPONENTS OF EVALUATIONCOMPONENTS OF EVALUATION
Growth dataGrowth data
HistoryHistory: : Problem contextProblem context , , MedicalMedical , ,
NutritionalNutritional , , PsychosocialPsychosocial , ,
Developmental/behavioralDevelopmental/behavioral
Physical examinationPhysical examination
Developmental/behavioral assessmentDevelopmental/behavioral assessment
Observation of a feedingObservation of a feeding
Laboratory studiesLaboratory studies
HospitalizationHospitalization
35. Growth dataGrowth data
Current growth parametersCurrent growth parameters
Growth curves over timeGrowth curves over time
Relationship of growth parameters to eachRelationship of growth parameters to each
otherother
36. HistoryHistory
Problem contextProblem context
When growth problem first became a When growth problem first became a
concernconcern
Previous interventions attemptedPrevious interventions attempted
37. Medical historyMedical history
Prenatal care and complications (infection, Prenatal care and complications (infection,
maternal nutrition, drug exposure)maternal nutrition, drug exposure)
Gestational age and growth parameters at birth Gestational age and growth parameters at birth
(SGA, prematurity)(SGA, prematurity)
Perinatal complications (infections, CNS Perinatal complications (infections, CNS
insults, anomalies)insults, anomalies)
40. Schedule and length of feedingsSchedule and length of feedings
Daily feeding/mealtime environmentDaily feeding/mealtime environment
Location/positioning during feedingsLocation/positioning during feedings
Perceptions of suck, swallow, and grasp of nipplePerceptions of suck, swallow, and grasp of nipple
Caregivers involved with feedingsCaregivers involved with feedings
41. Amount and type of mealtimeAmount and type of mealtime
supervisionsupervision
Behavior during feedingBehavior during feeding
History of progression to solid/table foods History of progression to solid/table foods
Favorite/disliked foods Favorite/disliked foods
Parental knowledge/beliefs regarding Parental knowledge/beliefs regarding
child/infant feedingchild/infant feeding
Family eating practices and beliefs Family eating practices and beliefs
Financial constraints affecting food Financial constraints affecting food
45. Physical examinationPhysical examination
Physician and child interactionPhysician and child interaction
Skinfold measurementsSkinfold measurements
Complete physical examinationComplete physical examination
46. Observation of a feedingObservation of a feeding
Feeding environment (home observation)Feeding environment (home observation)
Type and amount of food offeredType and amount of food offered
Duration of feedingDuration of feeding
Child's oromotor and fine motor skillsChild's oromotor and fine motor skills
48. Hospitalize if:Hospitalize if:
Evidence of physical abuse and/or severe Evidence of physical abuse and/or severe
neglectneglect
High risk for abuse and neglect, very disturbed High risk for abuse and neglect, very disturbed
parent & child interaction, poor parent functioning, parent & child interaction, poor parent functioning,
and/or an extremely stressful environmentand/or an extremely stressful environment
Severe malnutrition and/or medically unstableSevere malnutrition and/or medically unstable
Outpatient management failure Outpatient management failure